GE Funds Health Care for Underserved in Chicago; FedEx Healthcare Industry Summit Studies Solutions; New Pfizer and Quest Diagnostics Study Compares HIV Tests - Health Minute for October 10, 2012
GE has been acknowledged by the Chicago Department of Public Health at the halfway point of its two-year, $1.25 million grant program that started in 2011. Five non-profits and many volunteers, supported by the grant from the GE Foundation for the Developing Health Chicago program, have worked to increase access to primary health care for underserved communities. The many accomplishments of the program after a year’s work were celebrated in a recent event at the Howard Brown Health Center.
The FedEx Healthcare Industry Summit held in New York City focused on “borderless” health care in an interconnected world. Presenters and attendees discussed how the industry, from R&D and manufacturing to caregivers, could develop more and better solutions to meet the changing dynamics of a global healthcare industry. FedEx showcased a portfolio of its new products and service solutions, from innovations in cold chain technologies to temperature-controlled shipping capabilities with increased speed and reach.
A new study from researchers at Quest Diagnostics and Pfizer reveals that a laboratory-developed blood test using deep-sequencing technology performed comparably to the industry’s current, standard phenotypic test in predicting clinical response to HIV antiretroviral therapy. The study’s findings confirm the potential of advanced sequencing technologies to help in cost-effective management of HIV patients.
For more information on these and other stories, go to 3blmedia.com